MD

Manjul Dixit

Active Director Director DIN 01817199
DIN 01817199 First appointment Nov 2007 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2007
Shareholding value •••• Premium profile

About Manjul Dixit

Data last updated:

Manjul Dixit is a Director at Medisafe Pharmaceuticals Private Limitd (since 2007). The company operates in Trading. Medisafe Pharmaceuticals Private Limitd reported revenue of ₹14 Lakh (FY 2025).

DIN 01817199
Primary Designation Director
Industry Trading
First Appointment 05 Nov 2007
Oldest Company Age 18 yrs
Largest company Medisafe Pharmaceuticals Private Limitd · ₹14 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director05 Nov 20072007₹14 Lakh (FY 2025)Active

Board colleagues of Manjul Dixit

NameDINCompanyDesignation
Arvind Bhidola01855834Medisafe Pharmaceuticals Private LimitdDirector

Directorship timeline

Open interactive timeline →
Medisafe Pharmaceuticals Private Limitd
Premium access

Shareholding and investment profile for Manjul Dixit

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manjul Dixit

Manjul Dixit currently holds 1 directorship: Medisafe Pharmaceuticals Private Limitd (Director, since 05 Nov 2007, revenue ₹14 Lakh (FY 2025)).

Manjul Dixit was first appointed on 05 Nov 2007 as Director at Medisafe Pharmaceuticals Private Limitd.

The current boards of Manjul Dixit's companies include Arvind Bhidola (Medisafe Pharmaceuticals Private Limitd).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available